To the full analysis
MedinCell stock: growth
MEDCL.PAMedinCell reported $21.63M in revenue for fiscal 2026, down 23.6% on the prior year, up 19% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9%
per year from 2016 to 2026, per share −0.5%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | |
|---|---|---|
| Revenue | 19.0% | 9.0% |
| Revenue per share | 7.9% | −0.5% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | no data | no data |
| Free cash flow per share | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2016 | $9.12M | $689.24K | −$1.21M |
| 2017 | $9.46M | −$3.95M | −$5.79M |
| 2018 | $7.13M | −$10.61M | −$7.33M |
| 2019 | $1.6M | −$21.82M | −$18.49M |
| 2020 | $3.16M | −$26.5M | −$14.92M |
| 2021 | $9.07M | −$21.08M | −$14.36M |
| 2022 | $4.53M | −$27.49M | −$25.86M |
| 2023 | $11.02M | −$35.47M | −$24.41M |
| 2024 | $10.15M | −$27.74M | −$14.53M |
| 2025 | $28.3M | −$20.43M | $19.73M |
| 2026 | $21.63M | −$34.67M | −$29.47M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Sep 2019)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.